Home Search Abstracts Browse Sessions Program Committee Conference Webcasts Contact Us

Session 104   Poster Abstracts
Systemic and Organ Complications of HIV-1 and Antiretroviral Therapies
Monday, 1:30 - 3:30 pm
Poster Hall
746Risk of Acute Pancreatitis among HIV-infected Patients Who Developed Marked Hypertriglyceridemia after Receiving Antiretroviral Therapy
C-C Hung*, M-Y Chen, W-H Sheng, S-M Hsieh, W-C Liu, C-H Wu, and S-C Chang
Natl. Taiwan Univ. Hosp., Taipei
747HAART-associated Hepatotoxicity in HIV/HCV Co-infected Patients: Correlation with Liver Histologic Stage
J Moya*, L Aranzabal, J L Casado, S Diz, C Quereda, A Moreno, L Moreno, M J Perez-Elías, A Antela, A Marín, and S Moreno
Ramon y Cajal Hosp., Madrid, Spain
748
Carriage of HLA-B*5701 and a Haplotypic Hsp70-Hom Variant Is Associated with a Class I MHC-restricted Hypersensitivity Response to Abacavir
A M Martin*1, C A Almeida1, D Nolan1, S Gaudieri1,2, I James1, F T Christiansen2,3, A W Purcell4, J McCluskey4, and S Mallal1
1Royal Perth Hosp., Murdoch Univ., Australia; 2Univ. of Western Australia; 3Royal Perth Hosp., Australia; and 4Univ. of Melbourne, Victoria, Australia
749
Unexpected CD4 Cell-count Decline in Patients Receiving Didanosine- and Tenofovir-based Regimens Despite Undetectable Viral Load
E Negredo*1, J Moltó1, D Burger2, P Viciana3, E Ribera4, J Puig1, R Paredes1, L Ruiz1, A Pruvost5, J Grassi5, and B Clotet1
1Lluita contra la SIDA Fndn. and “Irsicaixa” Fndn., Germans Trias i Pujol Hosp., Barcelona, Spain; 2Nijmegen Univ. Hosp., The Netherlands; 3Virgen del Rocio Univ. Hosp., Seville, Spain; 4Vall d’Hebron Hosp., Barcelona, Spain; and 5CEA Pharmacology and Immunology Unit, Saclay, France
750Use of Estimated Glomerular Filtration Rate to Predict Renal Toxicity in Patients Receiving Tenofovir DF
M Harris*1, N Zalunardo2, S Bonner1, R Werb2, M Valyi1, and J S G Montaner1
1British Columbia Ctr. for Excellence in HIV/AIDS, Vancouver, Canada and 2St. Paul's Hosp., Vancouver, Canada
751Changes in Renal Function in Patients Treated with Tenofovir DF vs Nucleoside Reverse Transcriptase Inhibitors
M A Parish*, J E Gallant, and R Moore
Johns Hopkins Univ. Sch. of Med., Baltimore, MD, USA
752
HIV Nephropathy in Children Detected by Quantitative Proteinuria
A Chaparro*, G Zilleruelo, D Rivera, W Hanekom, G Scott, G Baldarrago, E Lopez, J Strauss, B Djorik, and C Mitchell
Univ. of Miami, FL, USA
753Endocrinologic Abnormalities and Impaired Growth in HIV-infected Children
C Chantry*1, M Frederick2, W Meyer3, E Handelsman4, D Turpin5, M Paul6, S Adeniyi-Jones7, J Moye8, and the Women and Infants Transmission Study (WITS)
1Univ. of California, Davis, USA; 2Clin. Trials & Surveys Corp., Baltimore, MD, USA; 3Quest Diagnostics Inc., Baltimore, MD, USA; 4State Univ. of New York Hlth. Sci. Ctr., Brooklyn, USA; 5Univ. of Illinois at Chicago, USA; 6Baylor Coll. of Med., Houston TX, USA; 7NIAID, NIH, DHHS, Bethesda, MD, USA; and 8NICHD, NIH, DHHS, Bethesda, MD, USA
754
Low-grade Symptoms Worsen Quality of Life for HIV-infected Individuals in Antiretroviral Therapy Clinical Trials
S Mannheimer*1, J Matts2, C Child3, M Chesney4, E Telzak5, A Wu6, G Friedland7, and the Terry Beirns Community Programs for Clinical Research on AIDS (CPCRA)
1Harlem Hosp./Columbia Univ., New York, NY, USA; 2CPCRA Statistical and Data Monitoring Ctr., Minneapolis, MN, USA; 3Univ. of California, San Francisco, USA; 4Natl. Ctr. for Complementary and Alternative Med., NIH, DHHS, Bethesda, MD, USA; 5Bronx Lebanon Hosp. Ctr., Albert Einstein Coll. of Med., Bronx, NY, USA; 6Johns Hopkins Univ., Baltimore, MD, USA; and 7Yale Univ. Sch. of Med., New Haven, CT, USA